【DT新材料】 获悉，近日， 中维化纤 完成数亿元B轮融资，由尚颀资本及 上汽集团 战略直投基金、中建材及容亿资本联合投资 。 中维化纤股份有限公司 成立于2015年，是国家级专精特新"小巨人"企业。公司第二大股东为化工巨头 华峰集团 。作为尼龙66特种功能性纤维领域的领 先企业，中维化纤不仅是世界第七家，更是国内首家生产 尼龙66汽车安全气囊丝 的民族企业。公司于2016年首台设备投产，2017年启动并通过了 华 懋、惠太、邦维 等下游及气囊总成企业的验证，最终在2021年实现规模化量产。 安全气囊 一直是汽车行业及消费者关注的焦点之一，目前， 全球安全气囊领域的知名 企业有 瑞典奥托立夫、日本高田、美国天合、德国采埃孚、美国 百利得 等； 中国在汽车安全气囊领域的研发起步较晚，主要生产企业有 锦州锦恒､东方久乐 和 华懋科技 等，其中， 东方久乐 是目前国内完全掌握汽 车安全气囊系统核心技术、拥有完全自主知识产权并实现产业化的本土企业。 说明： 本文部分素材来自于 中维化纤等 各大公司官网及 网络公开信息，由作者重新编写，系作者个人观点，本平台发布仅为了传达一种不同观点，不代表对该观点赞同或支持。如果有任 ...

7月1日晚间，沪深两市多家上市公司发布公告，以下是第一财经对一些重要公告的汇总，供投资者 参考。 【品大事】 新大陆：设立境外子公司并取得美国MSB牌照 新大陆(000997)公告，为加快支付全产业链的全球化布局，推进跨境支付业务的拓展，公司控股子 公司上海杉昊智能科技发展有限公司的全资子公司香港星驿支付有限公司出资1美元设立NovaPay US Inc.（简称"NovaPay"）。近日，公司获悉NovaPay已设立完成，取得公司注册证明书，并经 美国FinCEN批准授予MSB牌照。公司获取美国MSB牌照，旨在为开展跨境资金业务提供合法准入 资质，覆盖货币兑换、汇款、数字货币交易等场景，为对接全球主流金融机构提供基础设施，奠定跨 境支付相关业务开展的基础，助力公司全球化战略布局。 浙江黎明：实控人方面承诺1年内不减持公司股份 2025.07. 01 昂利康：公司目前在研创新药项目仅有一个 昂利康(002940)发布股票交易异动公告称，近期市场对创新药业务关注度较高，公司目前在研的创 新药项目仅有一个，系ALK-N001项目，该项目于2025年4月获得药物临床试验批准通知书，截至 目前，该项目尚处于I期临床试验 ...

一、停复牌 2、上纬新材：控股股东正在筹划重大事项，该事项可能导致公司控制权变更，股票停牌。 二、并购重组 风范股份：拟4800万元收购扬州旭樱8个光伏电站项目公司100%股权。 三、投资合作、经营状况 1、新大陆：设立境外子公司并取得美国MSB牌照，覆盖数字货币交易等场景。 2、国芯科技：公司中标汽车安全气囊点火驱动芯片项目，总价4600万元。 3、仙鹤股份：拟投资约110亿元建设竹浆纸用一体化高性能纸基新材料项目。 4、模塑科技：获北美知名电动车企外饰件产品项目定点，预计总销售额12.36亿元。 5、长春高新：拟授权公司管理层启动境外发行股份并在香港联交所上市。 1、杭州高新：控股股东变更为巨融伟业，股票复牌。 6、赛力斯：6月新能源汽车销量46086辆，同比增长4.44%。1-6月累计销量为17.21万辆，同比下降 14.35%。 8、长城汽车：6月销量为11.07万台，同比增长12.86%。 四、业绩变动 1、孩子王：预计2025年上半年净利润为1.2亿元-1.6亿元，同比增长50.00%-100.00%。 2、国脉科技：预计上半年净利润为1.25亿元-1.56亿元，同比增长60.52%-100.33 ...

7月1日晚间，沪深两市多家上市公司发布公告，以下是第一财经对一些重要公告的汇总，供投资者参 考。 【品大事】 新大陆：设立境外子公司并取得美国MSB牌照 新大陆(000997)公告，为加快支付全产业链的全球化布局，推进跨境支付业务的拓展，公司控股子公司 上海杉昊智能科技发展有限公司的全资子公司香港星驿支付有限公司出资1美元设立NovaPay US Inc. （简称"NovaPay"）。近日，公司获悉NovaPay已设立完成，取得公司注册证明书，并经美国FinCEN批 准授予MSB牌照。公司获取美国MSB牌照，旨在为开展跨境资金业务提供合法准入资质，覆盖货币兑 换、汇款、数字货币交易等场景，为对接全球主流金融机构提供基础设施，奠定跨境支付相关业务开展 的基础，助力公司全球化战略布局。 *ST元成(603388)公告，公司，公司控股股东、实控人祝昌人当日收到证监会《立案告知书》，因公司 涉嫌年报等定期报告财务数据虚假披露，证监会决定对公司，公司控股股东、实控人祝昌人立案。若后 续经证监会行政处罚认定的事实，触及重大违法强制退市情形，公司股票将被实施重大违法强制退市。 昂利康：公司目前在研创新药项目仅有一个 昂利康 ...

Group 1 - TaiLong Pharmaceutical plans to apply for the registration and issuance of super short-term financing bonds not exceeding 800 million yuan, with a maturity of no more than 270 days, for purposes including replacing bank loans and supplementing working capital [1] - GuoXin Technology won a bid for a 46 million yuan automotive airbag ignition driver chip project, indicating its growing presence in the automotive semiconductor market [1] - GuoMai Technology expects a net profit increase of 60.52% to 100.33% for the first half of 2025, with a projected net profit of 125 million to 156 million yuan [2] Group 2 - ChangAluminum's subsidiary signed a 165 million yuan contract for the customized construction of a clinical and industrial base for a vaccine project, highlighting its involvement in the biopharmaceutical sector [3] - ZhongSalt Chemical acquired exploration rights for natural soda ash in Inner Mongolia for 929,000 yuan, expanding its resource base [4] - Six Kingdom Chemical announced the resignation of its deputy general manager, which may impact its operational strategy [5][6] Group 3 - FuYuan Pharmaceutical received a drug registration certificate for Bisoprolol Amlodipine tablets, indicating its expansion in the hypertension treatment market [7][8] - GuanShi Technology's subsidiary received a government subsidy of 7 million yuan, which is 45.29% of its net profit for the previous year, enhancing its financial position [9] - XiZhong Technology plans to repurchase shares worth between 75 million and 150 million yuan, aimed at employee stock ownership plans or equity incentives [10] Group 4 - BeiLu Pharmaceutical's subsidiary received approval for the raw material drug Iopromide, which is used as a contrast agent for various imaging examinations [12] - HongHui New Materials obtained a patent for a water-based protective paint for hardware parts, enhancing its product portfolio [13] - BoJi Pharmaceutical's subsidiary received two patents related to high bioavailability formulations, indicating innovation in biopharmaceutical technology [14] Group 5 - ChengJian Development received a cash dividend of 23.625 million yuan from its investment in Huaneng Capital, contributing to its investment income [15] - JiuZhou Pharmaceutical's subsidiary received a drug registration certificate for Sildenafil Citrate orally disintegrating tablets, expanding its product offerings in the erectile dysfunction treatment market [16] - RuiAng Gene's subsidiary received a government subsidy of 176,290 yuan, supporting its operational activities [17] Group 6 - FengFan Technology plans to acquire 100% equity of a subsidiary for 48 million yuan, indicating strategic expansion in the renewable energy sector [18] - AoJing Medical's subsidiary received a medical device production license, allowing it to manufacture absorbable surgical dressings [19] - TaiLin Bio's subsidiary won land use rights for an industrial site, facilitating its high-performance filter project [20] Group 7 - KaiPu Bio received a patent for a method and device for analyzing genomic copy number variations, enhancing its capabilities in molecular diagnostics [21] - Shanghai KaiBao received a drug registration certificate for Phlegm-Heat Clearing Capsules, which can be used in the treatment of COVID-19 symptoms [23] - TuoJing Life received two patents for high uniformity streptavidin applications, improving its diagnostic product stability [25] Group 8 - AnKe Bio's AK2024 injection received approval for clinical trials, marking a significant advancement in cancer treatment [26] - HuanYuan Pharmaceutical expects a net profit of 142 million to 160 million yuan for the first half of 2025, reflecting substantial growth [27] - JinHongShun terminated a major asset restructuring plan due to a lack of consensus among parties involved, impacting its strategic direction [28] Group 9 - HeZhan Energy signed a 177 million yuan contract for the sale of steel-concrete tower structures, indicating strong demand in the renewable energy sector [29] - InSai Group's acquisition plan for an 80% stake in ZhiZheTongXing was accepted by the Shenzhen Stock Exchange, indicating growth in its consulting business [30] - JiuDian Pharmaceutical received a drug registration certificate for Zinc Granules, enhancing its product line in gastrointestinal treatments [32] Group 10 - GuoYao Modern plans to publicly transfer a 51% stake in its subsidiary to optimize resource allocation [34] - GuoYao Modern's subsidiary received a drug registration certificate for Perindopril Indapamide tablets, expanding its hypertension treatment portfolio [36] - ZhongGong International signed a 175 million yuan engineering consulting service contract, showcasing its capabilities in project management [38] Group 11 - China Railway won contracts worth approximately 5.343 billion yuan for overseas construction projects, indicating its strong international presence [39] - JunPu Intelligent signed a framework contract for humanoid robot sales worth about 28.25 million yuan, reflecting growth in the robotics sector [41] - Sinopec's chairman resigned due to age, which may lead to changes in corporate governance [42] Group 12 - JiuFeng Energy's controlling shareholder plans to reduce their stake by up to 0.71%, indicating potential changes in ownership structure [44] - Zhejiang Oriental's subsidiary plans to establish a 1.74 billion yuan equity investment fund, focusing on strategic emerging industries [46] - ChenGuang New Materials received a government subsidy of 26 million yuan, significantly impacting its financial performance [48]

国芯科技公告，公司收到一家汽车整机厂商关于供应汽车安全气囊点火驱动芯片项目的《中标通知 书》，中标产品总价为4600万元人民币(未税)。本次中标体现了客户对公司研发能力、产品质量、供应 链能力的充分认可，有利于进一步提升公司在汽车电子芯片市场竞争力及品牌形象。 ...

一季度促成意向订单超亿元 "专业高效的翻译服务不仅突破了语言沟通屏障，更让我们受德国采埃孚集团所青睐，有望斩获首张50 万欧元的外贸订单。"近日，浙江兆和化工有限公司总经理周兆良手持中德双语产品手册，信心满满地 说。 兆和化工是一家深耕汽车安全气囊化学品领域的企业。在智造新城管委会对接的译员团队帮助下，该公 司实现技术文件与安全标准的德文精准转化，通过德方技术评审，成为企业拓展欧洲市场的重要突破 口。 在智造新城另一家企业衢州力奥科技有限公司，外贸部经理陈倩倩正在整理即将发往墨西哥的竹纤维环 保家居样品。"管委会可帮大忙了！不仅帮我们抢到了2025墨西哥国际纺织展的黄金展位，还为我们铺 好了通往拉美市场的路。"陈倩倩感慨道，面对国际展会"一位难求"的现状，智造新城管委会依托全球 会展资源网络，为企业量身定制"出海服务包"，目前已经有30多家拉美采购商提前联系企业谈合作。 今年以来，智造新城主动作为，针对企业"出海"展销痛点，创新推出"展前政策辅导+展中问题处置+展 后物流保障"机制，助力外贸企业海外拓市。得益于此，浙江优柏智能科技有限公司在春季广交会期间 斩获四大洲客户订单超350万元，当场成交突破百万元，订 ...

Investment Rating - The report maintains a "Strong Buy" rating for the company [4][8]. Core Insights - The company is solidifying its position in the automotive safety sector while actively expanding into the semiconductor and computing power manufacturing fields, aligning with national strategic initiatives and high-quality development goals [1][3]. - The company has a market share exceeding 35% in the domestic automotive safety airbag industry and is expanding its overseas market presence, particularly in Southeast Asia through its Vietnam production base [4][2]. - The company is strategically investing in the semiconductor sector by acquiring a significant stake in Fuchuang Youyue, aiming for a complete acquisition to enhance its growth potential in this area [3][4]. Summary by Sections Strengthening Passive Safety Business and Embracing Overseas Markets - The company focuses on high-end, localized, and new energy directions for its automotive passive safety products, with a projected revenue of approximately 2.58 billion RMB from its Vietnam operations in 2024, reflecting a year-on-year growth of 32.23% [2][4]. - The company has established a stable production base in Vietnam, with 37 projects certified for mass production and 5 awaiting certification, targeting markets in Southeast Asia, Japan, South Korea, and India [2][4]. Entering the Computing Power Manufacturing Field - The company has invested a total of 383.36 million RMB in Fuchuang Youyue, acquiring a 42.16% stake, and plans to increase its ownership to 100% through a combination of cash and stock issuance [3][4]. - The company aims to enhance its business layout in the semiconductor and computing power sectors, focusing on integrating the supply chain and increasing investments in these areas [3][4]. Profit Forecast and Investment Recommendations - The company is projected to achieve a net profit of 497 million RMB in 2025, with a significant year-on-year growth of 79% [9][4]. - The report highlights the company's robust financial performance, with a total revenue forecast of 2.935 billion RMB for 2025, reflecting a 33% increase from the previous year [9][4].

星标 ★ IPO日报 精彩文章第一时间推送 5月20日晚间，华懋科技（下称"华懋科技"，603306.SH）发布公告称，其拟收购深圳市富创优越科技有限公司（下称"富创优 越"）部分股权。 本次交易完成后，华懋科技将直接及间接持有富创优越100%股权。本次交易预计构成重大资产重组，但不会导致控股股东、实 际控制人变更。 AI制图 持股100% 具体来看，华懋科技计划通过发行股份及支付现金的方式，购买富创优越约19.46%股权及富创优越股东深圳市洇锐科技有限公 司（下称"洇锐科技"）100%股权、深圳市富创优越壹号企业管理合伙企业（下称"富创壹号"）100%出资份额，同时拟发行股 份募集配套资金。 目前，洇锐科技和富创壹号分别持有富创优越约26.26%和约12.13%的股权。 本次交易前，华懋科技通过全资子公司持有富创优越42.16%股权。本次交易完成后，华懋科技将直接及间接持有富创优越 100%股权。 回顾华懋科技此前入股以来富创优越的过程，2024年9月、10月，华懋东阳合计以约2.38亿元的价格，取得了富创优越25%股 权。 今年1月，华懋科技公告称，华懋东阳先以6086.1万元，取得了富创优越7.16%股 ...

资料显示，华懋科技是汽车被动安全领域的龙头企业，产品线覆盖汽车安全气囊布、安全气囊袋以及安 全带等被动安全系统部件。业绩方面，华懋科技近年来表现不错，2022年至2024年，公司连续三年实现 营收净利双增长，2025年第一季度，其实现的营业收入为5.37亿元，同比增长14.37%；净利润为8642万 元，同比增长60.34%。 富创优越成立于2019年8月，主营业务涉及光模块的PCBA业务以及海事通信设备的研发生产等，可为 客户提供从产品研发、物料采购、生产制造到全球物流等一站式电子制造服务。截至2024年末，富创优 越总资产9.4亿元，2024年公司营业收入为13.2亿元，净利润为1.27亿元。 公告显示，洇锐科技、富创壹号分别持有富创优越26.2588%、12.1291%股权。 本次交易前，华懋科技通过全资子公司华懋东阳持有富创优越42.1602%股权，本次交易完成后，公司 将直接及间接持有富创优越100%股权。本次交易预计构成重大资产重组，但不会导致公司控股股东、 实际控制人变更。 华懋科技并未披露此次交易的价格。据其在2024年年报中透露，公司收购富创优越42.16%股权合计出 资约3.83亿元。由此 ...